| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |